254 related articles for article (PubMed ID: 20122798)
1. Presence of pharmaceutically active compounds in Doñana Park (Spain) main watersheds.
Camacho-Muñoz MD; Santos JL; Aparicio I; Alonso E
J Hazard Mater; 2010 May; 177(1-3):1159-62. PubMed ID: 20122798
[TBL] [Abstract][Full Text] [Related]
2. Occurrence, temporal evolution and risk assessment of pharmaceutically active compounds in Doñana Park (Spain).
Camacho-Muñoz D; Martín J; Santos JL; Aparicio I; Alonso E
J Hazard Mater; 2010 Nov; 183(1-3):602-8. PubMed ID: 20702036
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
Bendz D; Paxéus NA; Ginn TR; Loge FJ
J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain).
Santos JL; Aparicio I; Alonso E
Environ Int; 2007 May; 33(4):596-601. PubMed ID: 17084895
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of pharmaceutically active compounds in surface waters of the Henares-Jarama-Tajo River system (Madrid, Spain) and a potential risk characterization.
Fernández C; González-Doncel M; Pro J; Carbonell G; Tarazona JV
Sci Total Environ; 2010 Jan; 408(3):543-51. PubMed ID: 19889447
[TBL] [Abstract][Full Text] [Related]
6. Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid Region (Spain) and potential ecotoxicological risk.
Valcárcel Y; González Alonso S; Rodríguez-Gil JL; Gil A; Catalá M
Chemosphere; 2011 Sep; 84(10):1336-48. PubMed ID: 21641628
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of pharmaceutically active compounds on the Guadalquivir River basin (Spain): occurrence and risk assessment.
Martín J; Camacho-Muñoz D; Santos JL; Aparicio I; Alonso E
J Environ Monit; 2011 Jul; 13(7):2042-9. PubMed ID: 21666922
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of pharmaceutically active compounds during 1-year period in wastewaters from four wastewater treatment plants in Seville (Spain).
Santos JL; Aparicio I; Callejón M; Alonso E
J Hazard Mater; 2009 May; 164(2-3):1509-16. PubMed ID: 18990491
[TBL] [Abstract][Full Text] [Related]
9. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant.
Stackelberg PE; Furlong ET; Meyer MT; Zaugg SD; Henderson AK; Reissman DB
Sci Total Environ; 2004 Aug; 329(1-3):99-113. PubMed ID: 15262161
[TBL] [Abstract][Full Text] [Related]
10. The occurrence of acidic drugs and caffeine in sewage effluents and receiving waters from three coastal watersheds in Atlantic Canada.
Comeau F; Surette C; Brun GL; Losier R
Sci Total Environ; 2008 Jun; 396(2-3):132-46. PubMed ID: 18377954
[TBL] [Abstract][Full Text] [Related]
11. Sources of pharmaceutical pollution in the New York City Watershed.
Palmer PM; Wilson LR; O'Keefe P; Sheridan R; King T; Chen CY
Sci Total Environ; 2008 May; 394(1):90-102. PubMed ID: 18280543
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia.
Gracia-Lor E; Sancho JV; Serrano R; Hernández F
Chemosphere; 2012 Apr; 87(5):453-62. PubMed ID: 22221664
[TBL] [Abstract][Full Text] [Related]
13. An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarian, Hydra attenuata.
Quinn B; Gagné F; Blaise C
Sci Total Environ; 2008 Jan; 389(2-3):306-14. PubMed ID: 17931692
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of pharmaceuticals in aquatic biota (Procambarus clarkii) of the Doñana National Park (Spain).
Kazakova J; Villar-Navarro M; Ramos-Payán M; Aranda-Merino N; Román-Hidalgo C; Bello-López MÁ; Fernández-Torres R
J Environ Manage; 2021 Nov; 297():113314. PubMed ID: 34298344
[TBL] [Abstract][Full Text] [Related]
15. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients.
Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
Sci Total Environ; 2006 Jul; 364(1-3):67-87. PubMed ID: 16257037
[TBL] [Abstract][Full Text] [Related]
16. Illicit drugs: contaminants in the environment and utility in forensic epidemiology.
Daughton CG
Rev Environ Contam Toxicol; 2011; 210():59-110. PubMed ID: 21170703
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical contamination in residential, industrial, and agricultural waste streams: risk to aqueous environments in Taiwan.
Lin AY; Yu TH; Lin CF
Chemosphere; 2008 Dec; 74(1):131-41. PubMed ID: 18829065
[TBL] [Abstract][Full Text] [Related]
18. Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain).
Ginebreda A; Muñoz I; de Alda ML; Brix R; López-Doval J; Barceló D
Environ Int; 2010 Feb; 36(2):153-62. PubMed ID: 19931909
[TBL] [Abstract][Full Text] [Related]
19. Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies.
Ying GG; Kookana RS; Kolpin DW
J Environ Monit; 2009 Aug; 11(8):1498-505. PubMed ID: 19657534
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the presence of cardiovascular and analgesic/anti-inflammatory/antipyretic pharmaceuticals in river- and drinking-water of the Madrid Region in Spain.
Valcárcel Y; Alonso SG; Rodríguez-Gil JL; Maroto RR; Gil A; Catalá M
Chemosphere; 2011 Feb; 82(7):1062-71. PubMed ID: 21112611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
